A quantitative immunoassay to detect immunoglobulin G (IgG) antibodies directed against Beta-2 Glycoprotein I. The presence of this type of antibody (especially at high levels) is considered a strong laboratory criterion for diagnosing Antiphospholipid Syndrome (APS), and is often the most clinically significant type in terms of risk.